gip glp 1 drugs Targeting GLP-1, & GCG in Obesity and Type 2 Diabetes Research Upcoming wave of hormone-based therapies

GLP-1 receptor agonists in AD GLP-1 receptor agonists exert their effect on neuronal function by multiple mechanisms

Clinical trials stop after a few years, and some of the currently FDA-approved drugs have only been around for a couple of years

doi: 10.1016/j.jneuroim.2017.12.005 105 WuHYMaoXFFanHWangYX

While these numbers show effectiveness, they also suggest that expectations should be managed, especially given the significant financial investment

Introduction Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose cotransporter-2 (SGLT-2) inhibitors are second to third line antihyperglycaemic drugs commonly prescribed for the treatment of type 2 diabetes.12 Individually, these drugs have been shown to reduce the risk of cardiorenal events and mortality in large cardiovascular outcome trials.3456789 However, the combined effect of these drug classes on these outcomes has not been extensively studied

Bariatric surgery, very low calorie diets, and even aggressive exercise regimens can all cause telogen effluvium through the same mechanisms